Firm level R&D intensity: evidence from Indian drugs and pharmaceutical industry
Crossref DOI link: https://doi.org/10.1007/s11846-016-0218-8
Published Online: 2016-10-17
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tyagi, Shilpi http://orcid.org/0000-0003-2733-1355
Nauriyal, D. K.
Gulati, Rachita
Funding for this research was provided by:
University Grants Commission (IN)
License valid from 2016-10-17